. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Antiparkinson Agents/pharmacologyAntiparkinson Agents/therapeutic useHumansLevodopa/therapeutic useParkinson Disease/drug therapyPsychomotor Disorders/prevention & controlPsychomotor Performance/drug effectsRandomized Controlled Trials as Topic
Substances: See more » Antiparkinson AgentsLevodopa
Year: 2002 PMID: 12211137 DOI: 10.1002/mds.5558
Source DB: PubMed Journal: Mov Disord ISSN: 0885-3185 Impact factor: 10.338